{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:39:23Z","timestamp":1649101163192},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1980,2,1]],"date-time":"1980-02-01T00:00:00Z","timestamp":318211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1980,2]]},"DOI":"10.1007\/bf00431966","type":"journal-article","created":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T23:54:07Z","timestamp":1100130847000},"page":"125-130","source":"Crossref","is-referenced-by-count":7,"title":["The effects of naloxone on methylphenidate-induced mood and behavioral changes: A negative study"],"prefix":"10.1007","volume":"67","author":[{"given":"Leighton Y.","family":"Huey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Janowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis L.","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norton A.","family":"Roitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Clopton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donal","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","unstructured":"Arnsten, A., Segal, D. S.: Naloxone alters locomotion and interaction with environmental stimuli. Life Sci., in press (1979)","DOI":"10.1016\/0024-3205(79)90589-7"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1176\/ajp.128.6.688","volume":"128","author":"A. Beigel","year":"1971","unstructured":"Beigel, A., Murphy, D. L.: Assessing clinical characteristics of the manic state. Am. J. Psychiatry 128, 688?694 (1971)","journal-title":"Am. J. Psychiatry"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/266556a0","volume":"3661","author":"J. D. Belluzzi","year":"1977","unstructured":"Belluzzi, J. D., Stein, L.: Enkephalin may mediate euphoria and drive-reduction reward. Nature 3661, 556?668 (1977)","journal-title":"Nature"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0024-3205(77)90528-8","volume":"21","author":"J. F. Bruni","year":"1977","unstructured":"Bruni, J. F., Van Vogt, D., Marshall, S., Meites, J. Effects of naloxone, morphine, and methionine enkephalin on serum prolactin, luteinizing hormone, thyroid stimulating hormone and growth hormone. Life Sci. 21, 461?466 (1977)","journal-title":"Life Sci."},{"key":"CR5","doi-asserted-by":"crossref","unstructured":"Byck, R.: Peptide transmitters: A unifying hypothesis for euphoria, respiration, sleep, and the action of lithium. Lancet 1976II, 72?73","DOI":"10.1016\/S0140-6736(76)92289-3"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.325650","volume":"197","author":"G. C. Davis","year":"1977","unstructured":"Davis, G. C., Bunney, W. E., de Fraites, E. G., Kleinman, J. E., van Kammen, D. P., Post, R. M., Wyatt, R. J.: Intravenous naloxone administration in schizophrenic and affective illness. Science 197, 74?77 (1977)","journal-title":"Science"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0028-1094547","volume":"10","author":"H. M. Einrich","year":"1977","unstructured":"Einrich, H. M., Cording, C., Piree, S., Kolling, A., Zerssen, D., Herz, A.: Indication of an antipsychotic action of the opiate antagonist, naloxone. Pharmacopsychiatry 10, 265?270 (1977)","journal-title":"Pharmacopsychiatry"},{"key":"CR8","doi-asserted-by":"crossref","unstructured":"Gold, M. S., Redmond, D. E., Donabedian, R. K.: Prolactin secretion: A measurable central effect of opiate-receptor antagonists. Lancet 1978I, 323?324","DOI":"10.1016\/S0140-6736(78)90089-2"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2466\/pr0.1977.40.2.543","volume":"40","author":"R. A. Green","year":"1977","unstructured":"Green, R. A., Bigelow, L., O'Brien, P., Stahl, D., Wyatt, R. J.: The inpatient behavioral rating scale: A 26-item scale for recording nursing observations of patients' mood and behavior. Psychol. Rep. 40, 543?549 (1977)","journal-title":"Psychol. Rep."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01250276","volume":"40","author":"L. M. Gunne","year":"1977","unstructured":"Gunne, L. M., Linstrom, L., Terenius L.: Naloxone-induced reversal of schizophrenic hallucinations. J. Neural Transm. 40, 13?19 (1977)","journal-title":"J. Neural Transm."},{"key":"CR11","unstructured":"Hollt, V., Herz, A.: In vivo receptor occupation by opiates and correlation to the pharmacologic effect. Fed. Proc., in press (1977)"},{"key":"CR12","first-page":"51","volume":"189","author":"S. G. Holtzman","year":"1974","unstructured":"Holtzman, S. G.: Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J. Pharmacol. Exp. Ther. 189, 51?60 (1974)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"CR13","volume-title":"Ink blot technique: Administration and scoring guide","author":"W. Holtzman","year":"1961","unstructured":"Holtzman, W.: Ink blot technique: Administration and scoring guide. New York: Psychological Corp. 1961"},{"key":"CR14","unstructured":"Huey, L. Y., Janowsky, D. S., Judd, L. L., Abrams, A., Hubbard, B.: Methylphenidate antagonism by lithium. In: Abstracts of the New Research Section, p. 8: Annual Meeting of the American Psychiatric Association, Toronto, Canada, May 1977"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpsyc.1973.01750320023004","volume":"28","author":"D. S. Janowsky","year":"1973","unstructured":"Janowsky, D. S., El-Yousef, M., Davis, J.: Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch. Gen. Psychiatry 28, 185?191 (1973)","journal-title":"Arch. Gen. Psychiatry"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archpsyc.1977.01770140079009","volume":"34","author":"D. S. Janowsky","year":"1977","unstructured":"Janowsky, D. S., Huey, L. Y., Storms, L., Judd, L. L.: Methylphenidate hydrochloride effects on psychological tests in acute schizophrenic and nonpsychotic patients. Arch. Gen. Psychiatry 34, 189?194 (1977a)","journal-title":"Arch. Gen. Psychiatry"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00492367","volume":"53","author":"D. S. Janowsky","year":"1977","unstructured":"Janowsky, D. S., Segal, D. S., Abrams, A., Bloom, F., Guillemin, R.: Negative naloxone effects in schizophrenic patients. Psychopharmacology 53, 295?297 (1977b)","journal-title":"Psychopharmacology"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(78)91725-7","volume":"II","author":"D. S. Janowsky","year":"1978","unstructured":"Janowsky, D. S., Judd, L. L., Huey, L. Y., Roitman, N., Parker, D., Segal, D. S.: Naloxone effects on manic symptoms and growth hormone levels. Lancet II, 320 (1978a)","journal-title":"Lancet"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1001\/archpsyc.1978.01770350110011","volume":"35","author":"D. S. Janowsky","year":"1978","unstructured":"Janowsky, D. S., Leichner, P., Parker, D., Judd, L. L., Huey, L. Y., Clopton, P.: Methylphenidate effects on serum growth hormone: Influence of antipsychotic drugs and diagnosis. Arch. Gen. Psychiatry 35, 1384?1389 (1978b)","journal-title":"Arch. Gen. Psychiatry"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00426788","volume":"58","author":"D. S. Janowsky","year":"1978","unstructured":"Janowsky, D. S., Leichner, P., Parker, D., Judd, L. L., Huey, L. Y., Clopton, P.: Methylphenidate and serum prolactin in man. Psychopharmacology 58, 43?47 (1978c)","journal-title":"Psychopharmacology"},{"key":"CR21","doi-asserted-by":"crossref","unstructured":"Janowsky, D. S., Judd, L. L., Huey, L. Y.: Methylphenidate-induced changes in behavior, growth hormone, and prolactin. In: Catecholamines: Basic and clinical frontiers, E. Usdin, ed., in press, 1979","DOI":"10.1016\/B978-1-4832-8363-0.50585-1"},{"key":"CR22","unstructured":"Judd, L. L., Janowsky, D. S., Segal, D. S., Huey, L. Y.: Effects of IV naloxone on manic patients and normals. In: Abstracts of the New Research Section, p. 8: Annual Meeting of the American Psychiatric Association, Atlanta, GA, U.S.A., May 1978"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archpsyc.1977.01770160097008","volume":"34","author":"L. L. Judd","year":"1977","unstructured":"Judd, L. L., Hubbard, B., Huey, L. Y., Attewell, P. A., Janowsky, D. S., Takahashi, K. I.: The effect of lithium carbonate upon ethanol-induced ?highs? in normals. Arch. Gen. Psychiatry. 34, 463?467 (1977)","journal-title":"Arch. Gen. Psychiatry"},{"key":"CR24","volume-title":"EITS manual for the profile of mood states (research version)","author":"D. McNair","year":"1971","unstructured":"McNair, D., Lorr, M., Droppleman, L.: EITS manual for the profile of mood states (research version). San Diego: Educational and Testing Service 1971"},{"key":"CR25","volume-title":"Word association norms: Grade school through college","author":"D. Palermo","year":"1964","unstructured":"Palermo, D., Jenkins, J.: Word association norms: Grade school through college. Minneapolis: University of Minnesota Press 1964"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jcem-29-6-871","volume":"29","author":"D. C. Parker","year":"1969","unstructured":"Parker, D. C., Sassin, J. F., Mace, J. W.: Human growth hormone release during sleep: Electroencephalographic correlation. J. Clin. Endocrinol. Metab. 29, 871?874 (1969)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jcem-36-6-1119","volume":"36","author":"D. C. Parker","year":"1973","unstructured":"Parker, D. C., Rossman, L. G., Vanderlaan, E. F.: Sleep-related nyctohumoral and briefly episodic variation in human plasma prolactin concentrations. J. Clin. Endocrinol. Metab. 36, 119?124 (1973)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR28","first-page":"153","volume-title":"International review of research in mental retardation, vol. 1","author":"R. M. Reitan","year":"1966","unstructured":"Reitan, R. M.: A research program on the psychological effects of brain lesions in human beings. In: International review of research in mental retardation, vol. 1, N. R. Ellis, ed., pp. 153?214. New York: Academic 1966"},{"key":"CR29","first-page":"377","volume-title":"Characteristics and function of opioids, developments in neuroscience, vol. 4","author":"D. S. Segal","year":"1978","unstructured":"Segal, D. S., Browne, R. G., Arnsten, A., Derrington, D. C.: Behavioral effects in beta-endorphin. In: Characteristics and function of opioids, developments in neuroscience, vol. 4, J. M. Van Ree, L. Terenius, eds., pp. 377?388. Amsterdam: Elsevier 1978"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-349-04015-5_28","volume-title":"Endorphins in mental health research","author":"D. S. Segal","year":"1979","unstructured":"Segal, D. S., Browne, R. G., Derrington, D. C., Arnsten, A., Bloom, F. E., Davis, A. V., Guillermin, R., Ling, N.: Characteristics of ?-endorphin-induced behavioral activation and immobilization. In: Endorphins in mental health research, E. Usdin, B. E. Bunney, N. Kline, eds., pp. 307?324. London: MacMillan 1979"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0024-3205(77)90415-5","volume":"21","author":"C. J. Sharr","year":"1977","unstructured":"Sharr, C. J., Frederickson, R. C. A., Dininger, M. B., Jackson, L.: Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin: Evidence for regulation by an endogenous opioid peptide in brain. Life Sci. 21, 853?860 (1977)","journal-title":"Life Sci."},{"key":"CR32","volume-title":"Research diagnositic criteria","author":"R. L. Spitzer","year":"1975","unstructured":"Spitzer, R. L., Endicott, J., Robins, E.: Research diagnositic criteria. New York: New York State Department of Mental Hygiene and New York State Psychiatric Institute Biometrics Research 1975"},{"key":"CR33","volume-title":"Schedule for affective disorders and schizophrenia (SADS)","author":"R. L. Spitzer","year":"1975","unstructured":"Spitzer, R. L., Endicott, J.: Schedule for affective disorders and schizophrenia (SADS) New York: New York State Psychiatric Institute Biometrics Research 1975"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0304-3940(76)90086-0","volume":"3","author":"L. A. Terenius","year":"1976","unstructured":"Terenius, L. A., Wahlstrom, A., Lindstrom, L., Widerlov, E.: Increased CSF levels of endorphins in chronic psychosis. Neurosci. Letters 3, 157?162 (1976)","journal-title":"Neurosci. Letters"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00428897","volume":"44","author":"D. P. Kammen van","year":"1975","unstructured":"van Kammen, D. P., Murphy, D. L.: Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacology 44, 215?224 (1975)","journal-title":"Psychopharmacology"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.860138","volume":"196","author":"J. A. Volavka","year":"1977","unstructured":"Volavka, J. A., Mallya, A., Baig, S., Perez-Cruet, J.: Naloxone in chronic schizophrenia. Science 196, 1227?1228 (1977)","journal-title":"Science"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.351804","volume":"201","author":"S. J. Watson","year":"1978","unstructured":"Watson, S. J., Berger, P. A., Akil, H., Mills, M. J., Barchas, J. D.: Effects of naloxone on schixophrenia: Reduction in hallucinations in a subpopulation of subjects. Science 201, 73?76 (1978)","journal-title":"Science"},{"key":"CR38","volume-title":"Manual for the Wechsler adult intelligence scale","author":"D. Wechsler","year":"1955","unstructured":"Wechsler, D.: Manual for the Wechsler adult intelligence scale. New York: Psychological Corp. 1955"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431966.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00431966\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:39:51Z","timestamp":1554835191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00431966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1980,2]]}},"alternative-id":["BF00431966"],"URL":"https:\/\/doi.org\/10.1007\/bf00431966","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,2]]}}}